OCMAX | OGMYX | OCMAX / OGMYX | |
Total Expense Ratio | 1.94 | 0.86 | 226% |
Annual Report Gross Expense Ratio | 1.94 | 0.86 | 226% |
Fund Existence | 15 years | 15 years | - |
Gain YTD | 25.953 | 14.741 | 176% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 82.7M | 2.15B | 4% |
Annual Yield % from dividends | 1.72 | 0.80 | 215% |
Returns for 1 year | 37.00 | 18.31 | 202% |
Returns for 3 years | 16.15 | 1.07 | 1,512% |
Returns for 5 years | 86.95 | 67.14 | 129% |
Returns for 10 years | 77.42 | 165.28 | 47% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FDWM | 20.80 | 1.77 | +9.28% |
Fidelity Women's Leadership ETF | |||
AVSD | 57.87 | 4.03 | +7.48% |
Avantis Responsible International Eq ETF | |||
FMED | 22.85 | 1.42 | +6.63% |
Fidelity Disruptive Medicine ETF | |||
ACIO | 37.97 | 1.61 | +4.44% |
Aptus Collared Investment Opp ETF | |||
TBUX | 49.58 | -0.01 | -0.02% |
T. Rowe Price Ultra Short-Term Bond ETF |